A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1995-03

AUTHORS

Gordon L. Amidon, Hans Lennernäs, Vinod P. Shah, John R. Crison

ABSTRACT

A biopharmaceutics drug classification scheme for correlating in vitro drug product dissolution and in vivo bioavailability is proposed based on recognizing that drug dissolution and gastrointestinal permeability are the fundamental parameters controlling rate and extent of drug absorption. This analysis uses a transport model and human permeability results for estimating in vivo drug absorption to illustrate the primary importance of solubility and permeability on drug absorption. The fundamental parameters which define oral drug absorption in humans resulting from this analysis are discussed and used as a basis for this classification scheme. These Biopharmaceutic Drug Classes are defined as: Case 1. High solubility-high permeability drugs, Case 2. Low solubility-high permeability drugs, Case 3. High solubility-low permeability drugs, and Case 4. Low solubility-low permeability drugs. Based on this classification scheme, suggestions are made for setting standards for in vitro drug dissolution testing methodology which will correlate with the in vivo process. This methodology must be based on the physiological and physical chemical properties controlling drug absorption. This analysis points out conditions under which no in vitro-in vivo correlation may be expected e.g. rapidly dissolving low permeability drugs. Furthermore, it is suggested for example that for very rapidly dissolving high solubility drugs, e.g. 85% dissolution in less than 15 minutes, a simple one point dissolution test, is all that may be needed to insure bioavailability. For slowly dissolving drugs a dissolution profile is required with multiple time points in systems which would include low pH, physiological pH, and surfactants and the in vitro conditions should mimic the in vivo processes.(ABSTRACT TRUNCATED AT 250 WORDS) More... »

PAGES

413-420

Identifiers

URI

http://scigraph.springernature.com/pub.10.1023/a:1016212804288

DOI

http://dx.doi.org/10.1023/a:1016212804288

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1037126380

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/7617530


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biological Availability", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cimetidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gastric Emptying", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "In Vitro Techniques", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Jejunum", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mathematics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Models, Theoretical", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Permeability", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pharmaceutical Preparations", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Piroxicam", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Solubility", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Michigan\u2013Ann Arbor", 
          "id": "https://www.grid.ac/institutes/grid.214458.e", 
          "name": [
            "College of Pharmacy, The University of Michigan, 48109-1065, Ann Arbor, Michigan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Amidon", 
        "givenName": "Gordon L.", 
        "id": "sg:person.014127067437.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014127067437.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Uppsala University", 
          "id": "https://www.grid.ac/institutes/grid.8993.b", 
          "name": [
            "School of Pharmacy, Uppsala University, Box 580, S-751 23, Uppsala, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lennern\u00e4s", 
        "givenName": "Hans", 
        "id": "sg:person.01372131203.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372131203.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Parenteral Drug Association", 
          "id": "https://www.grid.ac/institutes/grid.479064.8", 
          "name": [
            "PDA, HFD-602, 20857, Rockville, Maryland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shah", 
        "givenName": "Vinod P.", 
        "id": "sg:person.01223074603.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223074603.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "TSRL (United States)", 
          "id": "https://www.grid.ac/institutes/grid.281449.2", 
          "name": [
            "TSRL, Inc., 540 Avis Drive, Suite A, 48108, Ann Arbor, Michigan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Crison", 
        "givenName": "John R.", 
        "id": "sg:person.015752121734.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015752121734.07"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1023/a:1018999130076", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002102293", 
          "https://doi.org/10.1023/a:1018999130076"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.2600750202", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003026689"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.2600691204", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010541473"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.1994.tb04309.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013748502"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.2600730922", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016268446"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0378-5173(89)90069-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024346420"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0378-5173(89)90069-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024346420"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/10611869509015945", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027004040"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.1993.tb05691.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028323223"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/gut.27.8.886", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034298308"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1015892621261", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035241234", 
          "https://doi.org/10.1023/a:1015892621261"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01061761", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036555799", 
          "https://doi.org/10.1007/bf01061761"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1015909716312", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038769588", 
          "https://doi.org/10.1023/a:1015909716312"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/03639048309046315", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039109681"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1015888813741", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040826363", 
          "https://doi.org/10.1023/a:1015888813741"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1015927004752", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042556047", 
          "https://doi.org/10.1023/a:1015927004752"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.2600781111", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042647529"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00562664", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044388678", 
          "https://doi.org/10.1007/bf00562664"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00562664", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044388678", 
          "https://doi.org/10.1007/bf00562664"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0378-5173(80)90048-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045925554"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0378-5173(80)90048-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045925554"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1015829128646", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047482208", 
          "https://doi.org/10.1023/a:1015829128646"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1018947113238", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051994422", 
          "https://doi.org/10.1023/a:1018947113238"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076536863", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0016-5085(90)91150-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078478659"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1995-03", 
    "datePublishedReg": "1995-03-01", 
    "description": "A biopharmaceutics drug classification scheme for correlating in vitro drug product dissolution and in vivo bioavailability is proposed based on recognizing that drug dissolution and gastrointestinal permeability are the fundamental parameters controlling rate and extent of drug absorption. This analysis uses a transport model and human permeability results for estimating in vivo drug absorption to illustrate the primary importance of solubility and permeability on drug absorption. The fundamental parameters which define oral drug absorption in humans resulting from this analysis are discussed and used as a basis for this classification scheme. These Biopharmaceutic Drug Classes are defined as: Case 1. High solubility-high permeability drugs, Case 2. Low solubility-high permeability drugs, Case 3. High solubility-low permeability drugs, and Case 4. Low solubility-low permeability drugs. Based on this classification scheme, suggestions are made for setting standards for in vitro drug dissolution testing methodology which will correlate with the in vivo process. This methodology must be based on the physiological and physical chemical properties controlling drug absorption. This analysis points out conditions under which no in vitro-in vivo correlation may be expected e.g. rapidly dissolving low permeability drugs. Furthermore, it is suggested for example that for very rapidly dissolving high solubility drugs, e.g. 85% dissolution in less than 15 minutes, a simple one point dissolution test, is all that may be needed to insure bioavailability. For slowly dissolving drugs a dissolution profile is required with multiple time points in systems which would include low pH, physiological pH, and surfactants and the in vitro conditions should mimic the in vivo processes.(ABSTRACT TRUNCATED AT 250 WORDS)", 
    "genre": "research_article", 
    "id": "sg:pub.10.1023/a:1016212804288", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2511825", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2508276", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1094644", 
        "issn": [
          "0724-8741", 
          "1573-904X"
        ], 
        "name": "Pharmaceutical Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "name": "A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability", 
    "pagination": "413-420", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "b0db9cc6ccd51802b1e31cfa7c11aabc5ba1c73ba893c97a211d72b1b27abceb"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "7617530"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8406521"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1023/a:1016212804288"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1037126380"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1023/a:1016212804288", 
      "https://app.dimensions.ai/details/publication/pub.1037126380"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:41", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000506.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1023/A:1016212804288"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1023/a:1016212804288'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1023/a:1016212804288'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1023/a:1016212804288'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1023/a:1016212804288'


 

This table displays all metadata directly associated to this object as RDF triples.

221 TRIPLES      21 PREDICATES      62 URIs      32 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1023/a:1016212804288 schema:about N20252f6a36a44c80ae3254130ac29954
2 N495fb73755954156b558de5d2583f37b
3 N5e1f932fe7f049479b6773145bbedfd8
4 N607882f3364b401da32796c29cd20e49
5 N63b69a20218648b6a60cf89e0a3cce43
6 N7f1d7b68d3994c21af2566c816bfc405
7 Ndf8be077d831482e88661a2f3f499368
8 Ne9f271b0ad6d4010b018b2868565b6d7
9 Nee9323aa90d04877b2991a257cb1dbcd
10 Nf045a51dd3e548a0a2ebd8cf85763e47
11 Nfa8d2e7be4d04d6fb8c55969d840e380
12 anzsrc-for:11
13 anzsrc-for:1115
14 schema:author N54d2228b327d452598fd6c8817108cc7
15 schema:citation sg:pub.10.1007/bf00562664
16 sg:pub.10.1007/bf01061761
17 sg:pub.10.1023/a:1015829128646
18 sg:pub.10.1023/a:1015888813741
19 sg:pub.10.1023/a:1015892621261
20 sg:pub.10.1023/a:1015909716312
21 sg:pub.10.1023/a:1015927004752
22 sg:pub.10.1023/a:1018947113238
23 sg:pub.10.1023/a:1018999130076
24 https://app.dimensions.ai/details/publication/pub.1076536863
25 https://doi.org/10.1002/jps.2600691204
26 https://doi.org/10.1002/jps.2600730922
27 https://doi.org/10.1002/jps.2600750202
28 https://doi.org/10.1002/jps.2600781111
29 https://doi.org/10.1016/0016-5085(90)91150-5
30 https://doi.org/10.1016/0378-5173(80)90048-4
31 https://doi.org/10.1016/0378-5173(89)90069-0
32 https://doi.org/10.1111/j.1365-2125.1993.tb05691.x
33 https://doi.org/10.1111/j.1365-2125.1994.tb04309.x
34 https://doi.org/10.1136/gut.27.8.886
35 https://doi.org/10.3109/03639048309046315
36 https://doi.org/10.3109/10611869509015945
37 schema:datePublished 1995-03
38 schema:datePublishedReg 1995-03-01
39 schema:description A biopharmaceutics drug classification scheme for correlating in vitro drug product dissolution and in vivo bioavailability is proposed based on recognizing that drug dissolution and gastrointestinal permeability are the fundamental parameters controlling rate and extent of drug absorption. This analysis uses a transport model and human permeability results for estimating in vivo drug absorption to illustrate the primary importance of solubility and permeability on drug absorption. The fundamental parameters which define oral drug absorption in humans resulting from this analysis are discussed and used as a basis for this classification scheme. These Biopharmaceutic Drug Classes are defined as: Case 1. High solubility-high permeability drugs, Case 2. Low solubility-high permeability drugs, Case 3. High solubility-low permeability drugs, and Case 4. Low solubility-low permeability drugs. Based on this classification scheme, suggestions are made for setting standards for in vitro drug dissolution testing methodology which will correlate with the in vivo process. This methodology must be based on the physiological and physical chemical properties controlling drug absorption. This analysis points out conditions under which no in vitro-in vivo correlation may be expected e.g. rapidly dissolving low permeability drugs. Furthermore, it is suggested for example that for very rapidly dissolving high solubility drugs, e.g. 85% dissolution in less than 15 minutes, a simple one point dissolution test, is all that may be needed to insure bioavailability. For slowly dissolving drugs a dissolution profile is required with multiple time points in systems which would include low pH, physiological pH, and surfactants and the in vitro conditions should mimic the in vivo processes.(ABSTRACT TRUNCATED AT 250 WORDS)
40 schema:genre research_article
41 schema:inLanguage en
42 schema:isAccessibleForFree false
43 schema:isPartOf N2bcf9f334a634e9e800fc8c2706b0859
44 Na4465e25cbed48b883e43ddf1d584d79
45 sg:journal.1094644
46 schema:name A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability
47 schema:pagination 413-420
48 schema:productId N0090cd1f55dd4eb78858404056ac56ce
49 N0668c4f0449240d8b1e198b298ad68ab
50 N407aa8bcd342440a9e6c88d25ef8b007
51 N94749e74e6f0480aa4c33c33f2c42931
52 Nca0d8ee455ac4b2d99ce433955fb2e6d
53 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037126380
54 https://doi.org/10.1023/a:1016212804288
55 schema:sdDatePublished 2019-04-10T16:41
56 schema:sdLicense https://scigraph.springernature.com/explorer/license/
57 schema:sdPublisher Nbc348a6f9e504d1c81466cc6488e45e7
58 schema:url http://link.springer.com/10.1023/A:1016212804288
59 sgo:license sg:explorer/license/
60 sgo:sdDataset articles
61 rdf:type schema:ScholarlyArticle
62 N0090cd1f55dd4eb78858404056ac56ce schema:name nlm_unique_id
63 schema:value 8406521
64 rdf:type schema:PropertyValue
65 N0668c4f0449240d8b1e198b298ad68ab schema:name doi
66 schema:value 10.1023/a:1016212804288
67 rdf:type schema:PropertyValue
68 N20252f6a36a44c80ae3254130ac29954 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Mathematics
70 rdf:type schema:DefinedTerm
71 N2bcf9f334a634e9e800fc8c2706b0859 schema:volumeNumber 12
72 rdf:type schema:PublicationVolume
73 N407aa8bcd342440a9e6c88d25ef8b007 schema:name pubmed_id
74 schema:value 7617530
75 rdf:type schema:PropertyValue
76 N495fb73755954156b558de5d2583f37b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Pharmaceutical Preparations
78 rdf:type schema:DefinedTerm
79 N54d2228b327d452598fd6c8817108cc7 rdf:first sg:person.014127067437.90
80 rdf:rest N5b059d16103244e8b5ee17a8bd9ad9cf
81 N5b059d16103244e8b5ee17a8bd9ad9cf rdf:first sg:person.01372131203.73
82 rdf:rest Nb87e8e4d2a574de09c141a73989621a9
83 N5e1f932fe7f049479b6773145bbedfd8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Biological Availability
85 rdf:type schema:DefinedTerm
86 N607882f3364b401da32796c29cd20e49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Gastric Emptying
88 rdf:type schema:DefinedTerm
89 N63b69a20218648b6a60cf89e0a3cce43 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Permeability
91 rdf:type schema:DefinedTerm
92 N7f1d7b68d3994c21af2566c816bfc405 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Piroxicam
94 rdf:type schema:DefinedTerm
95 N88bf77e9025744fd9913fe5272e6ef54 rdf:first sg:person.015752121734.07
96 rdf:rest rdf:nil
97 N94749e74e6f0480aa4c33c33f2c42931 schema:name readcube_id
98 schema:value b0db9cc6ccd51802b1e31cfa7c11aabc5ba1c73ba893c97a211d72b1b27abceb
99 rdf:type schema:PropertyValue
100 Na4465e25cbed48b883e43ddf1d584d79 schema:issueNumber 3
101 rdf:type schema:PublicationIssue
102 Nb87e8e4d2a574de09c141a73989621a9 rdf:first sg:person.01223074603.31
103 rdf:rest N88bf77e9025744fd9913fe5272e6ef54
104 Nbc348a6f9e504d1c81466cc6488e45e7 schema:name Springer Nature - SN SciGraph project
105 rdf:type schema:Organization
106 Nca0d8ee455ac4b2d99ce433955fb2e6d schema:name dimensions_id
107 schema:value pub.1037126380
108 rdf:type schema:PropertyValue
109 Ndf8be077d831482e88661a2f3f499368 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Jejunum
111 rdf:type schema:DefinedTerm
112 Ne9f271b0ad6d4010b018b2868565b6d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name In Vitro Techniques
114 rdf:type schema:DefinedTerm
115 Nee9323aa90d04877b2991a257cb1dbcd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Models, Theoretical
117 rdf:type schema:DefinedTerm
118 Nf045a51dd3e548a0a2ebd8cf85763e47 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Solubility
120 rdf:type schema:DefinedTerm
121 Nfa8d2e7be4d04d6fb8c55969d840e380 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Cimetidine
123 rdf:type schema:DefinedTerm
124 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
125 schema:name Medical and Health Sciences
126 rdf:type schema:DefinedTerm
127 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
128 schema:name Pharmacology and Pharmaceutical Sciences
129 rdf:type schema:DefinedTerm
130 sg:grant.2508276 http://pending.schema.org/fundedItem sg:pub.10.1023/a:1016212804288
131 rdf:type schema:MonetaryGrant
132 sg:grant.2511825 http://pending.schema.org/fundedItem sg:pub.10.1023/a:1016212804288
133 rdf:type schema:MonetaryGrant
134 sg:journal.1094644 schema:issn 0724-8741
135 1573-904X
136 schema:name Pharmaceutical Research
137 rdf:type schema:Periodical
138 sg:person.01223074603.31 schema:affiliation https://www.grid.ac/institutes/grid.479064.8
139 schema:familyName Shah
140 schema:givenName Vinod P.
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223074603.31
142 rdf:type schema:Person
143 sg:person.01372131203.73 schema:affiliation https://www.grid.ac/institutes/grid.8993.b
144 schema:familyName Lennernäs
145 schema:givenName Hans
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372131203.73
147 rdf:type schema:Person
148 sg:person.014127067437.90 schema:affiliation https://www.grid.ac/institutes/grid.214458.e
149 schema:familyName Amidon
150 schema:givenName Gordon L.
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014127067437.90
152 rdf:type schema:Person
153 sg:person.015752121734.07 schema:affiliation https://www.grid.ac/institutes/grid.281449.2
154 schema:familyName Crison
155 schema:givenName John R.
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015752121734.07
157 rdf:type schema:Person
158 sg:pub.10.1007/bf00562664 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044388678
159 https://doi.org/10.1007/bf00562664
160 rdf:type schema:CreativeWork
161 sg:pub.10.1007/bf01061761 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036555799
162 https://doi.org/10.1007/bf01061761
163 rdf:type schema:CreativeWork
164 sg:pub.10.1023/a:1015829128646 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047482208
165 https://doi.org/10.1023/a:1015829128646
166 rdf:type schema:CreativeWork
167 sg:pub.10.1023/a:1015888813741 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040826363
168 https://doi.org/10.1023/a:1015888813741
169 rdf:type schema:CreativeWork
170 sg:pub.10.1023/a:1015892621261 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035241234
171 https://doi.org/10.1023/a:1015892621261
172 rdf:type schema:CreativeWork
173 sg:pub.10.1023/a:1015909716312 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038769588
174 https://doi.org/10.1023/a:1015909716312
175 rdf:type schema:CreativeWork
176 sg:pub.10.1023/a:1015927004752 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042556047
177 https://doi.org/10.1023/a:1015927004752
178 rdf:type schema:CreativeWork
179 sg:pub.10.1023/a:1018947113238 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051994422
180 https://doi.org/10.1023/a:1018947113238
181 rdf:type schema:CreativeWork
182 sg:pub.10.1023/a:1018999130076 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002102293
183 https://doi.org/10.1023/a:1018999130076
184 rdf:type schema:CreativeWork
185 https://app.dimensions.ai/details/publication/pub.1076536863 schema:CreativeWork
186 https://doi.org/10.1002/jps.2600691204 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010541473
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1002/jps.2600730922 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016268446
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1002/jps.2600750202 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003026689
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1002/jps.2600781111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042647529
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1016/0016-5085(90)91150-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078478659
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1016/0378-5173(80)90048-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045925554
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1016/0378-5173(89)90069-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024346420
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1111/j.1365-2125.1993.tb05691.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1028323223
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1111/j.1365-2125.1994.tb04309.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1013748502
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1136/gut.27.8.886 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034298308
205 rdf:type schema:CreativeWork
206 https://doi.org/10.3109/03639048309046315 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039109681
207 rdf:type schema:CreativeWork
208 https://doi.org/10.3109/10611869509015945 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027004040
209 rdf:type schema:CreativeWork
210 https://www.grid.ac/institutes/grid.214458.e schema:alternateName University of Michigan–Ann Arbor
211 schema:name College of Pharmacy, The University of Michigan, 48109-1065, Ann Arbor, Michigan
212 rdf:type schema:Organization
213 https://www.grid.ac/institutes/grid.281449.2 schema:alternateName TSRL (United States)
214 schema:name TSRL, Inc., 540 Avis Drive, Suite A, 48108, Ann Arbor, Michigan
215 rdf:type schema:Organization
216 https://www.grid.ac/institutes/grid.479064.8 schema:alternateName Parenteral Drug Association
217 schema:name PDA, HFD-602, 20857, Rockville, Maryland
218 rdf:type schema:Organization
219 https://www.grid.ac/institutes/grid.8993.b schema:alternateName Uppsala University
220 schema:name School of Pharmacy, Uppsala University, Box 580, S-751 23, Uppsala, Sweden
221 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...